IL-1-话题@MedSci

#IL-1#

184篇内容 | 4445人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1508313, encodeId=96901508313da, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=ARD：抑制IL-12/23（优特克单抗）与肿瘤坏死因子在银屑病关节炎中的有效性, objectType=article, longId=219933, objectId=b0dc21993361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0dc21993361, replyNumber=0, likeNumber=73, createdTime=2021-11-09, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0dc21993361, moduleTitle=ARD：抑制IL-12/23（优特克单抗）与肿瘤坏死因子在银屑病关节炎中的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0dc21993361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508312, encodeId=c09e15083129d, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Lancet Rheumatology: 抑制IL-1和IL-6影响COVID-19患者抗SARS-CoV-2抗体的中和活性, objectType=article, longId=219599, objectId=a5c321959961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5c321959961, replyNumber=0, likeNumber=102, createdTime=2021-11-03, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5c321959961, moduleTitle=Lancet Rheumatology: 抑制IL-1和IL-6影响COVID-19患者抗SARS-CoV-2抗体的中和活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5c321959961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508311, encodeId=3be11508311fa, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=J Invest Dermatol：IL-17A产生细胞在皮肤炎性疾病中的调节, objectType=article, longId=219328, objectId=722021932816, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=722021932816, replyNumber=0, likeNumber=69, createdTime=2021-10-28, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=722021932816, moduleTitle=J Invest Dermatol：IL-17A产生细胞在皮肤炎性疾病中的调节, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=722021932816)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508310, encodeId=75e9150831000, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=研究进展：细胞因子IL-10生物学和治疗潜力多样性详解, objectType=article, longId=213641, objectId=3a9d21364159, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a9d21364159, replyNumber=0, likeNumber=73, createdTime=2021-07-04, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a9d21364159, moduleTitle=研究进展：细胞因子IL-10生物学和治疗潜力多样性详解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a9d21364159)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508309, encodeId=41d91508309b0, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Arthritis Res Ther：IL-17抑制剂治疗强直性脊柱炎的疗效和安全性如何？, objectType=article, longId=210764, objectId=061a210e6467, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=061a210e6467, replyNumber=0, likeNumber=59, createdTime=2021-05-05, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=061a210e6467, moduleTitle=Arthritis Res Ther：IL-17抑制剂治疗强直性脊柱炎的疗效和安全性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=061a210e6467)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508308, encodeId=ebde150830828, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Lancet：IL-17A/F纳米体索洛奇单抗治疗斑块型银屑病II期临床获得成功, objectType=article, longId=210523, objectId=496421052350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=496421052350, replyNumber=0, likeNumber=94, createdTime=2021-04-28, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=496421052350, moduleTitle=Lancet：IL-17A/F纳米体索洛奇单抗治疗斑块型银屑病II期临床获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=496421052350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508307, encodeId=1e38150830ef3, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=BMC Gastroenterology：血浆中IL-17和甲胎蛋白的水平可有效预测肝硬化患者发生肝癌的风险, objectType=article, longId=210172, objectId=d8312101e256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8312101e256, replyNumber=0, likeNumber=64, createdTime=2021-04-20, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8312101e256, moduleTitle=BMC Gastroenterology：血浆中IL-17和甲胎蛋白的水平可有效预测肝硬化患者发生肝癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8312101e256)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508306, encodeId=8e7915083060b, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=BMC: 肠粘膜中IL-12表达增加与溃疡性结肠炎的复发有关, objectType=article, longId=208945, objectId=86172089459d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86172089459d, replyNumber=0, likeNumber=68, createdTime=2021-03-26, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86172089459d, moduleTitle=BMC: 肠粘膜中IL-12表达增加与溃疡性结肠炎的复发有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86172089459d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508305, encodeId=5def1508305b3, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=ASCO GU 2021: IL-15RαFc超激动剂N-803在对BCG反应的NMIBC膀胱癌原位癌患者中的研究（QUILT 3.032试验）, objectType=article, longId=207193, objectId=f13120e19316, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f13120e19316, replyNumber=0, likeNumber=74, createdTime=2021-02-18, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f13120e19316, moduleTitle=ASCO GU 2021: IL-15RαFc超激动剂N-803在对BCG反应的NMIBC膀胱癌原位癌患者中的研究（QUILT 3.032试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f13120e19316)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508304, encodeId=77ce1508304de, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Blood：IL-18介导镰状细胞性心肌病和室性心动过速的发生, objectType=article, longId=204378, objectId=e8dd2043e8be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8dd2043e8be, replyNumber=0, likeNumber=79, createdTime=2020-12-12, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8dd2043e8be, moduleTitle=Blood：IL-18介导镰状细胞性心肌病和室性心动过速的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8dd2043e8be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508303, encodeId=47fd150830353, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=恒瑞 IL-17A单抗SHR-1314用于强直性脊柱炎获批临床试验, objectType=article, longId=203507, objectId=ccd220350e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccd220350e2c, replyNumber=0, likeNumber=65, createdTime=2020-11-19, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccd220350e2c, moduleTitle=恒瑞 IL-17A单抗SHR-1314用于强直性脊柱炎获批临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccd220350e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508302, encodeId=24441508302e9, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Can J Cardiol：与环孢素或甲氨蝶呤治疗相比，抑制IL-17A可使血管和心肌功能得到更大的改善, objectType=article, longId=203363, objectId=1f8720336334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f8720336334, replyNumber=0, likeNumber=60, createdTime=2020-11-15, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f8720336334, moduleTitle=Can J Cardiol：与环孢素或甲氨蝶呤治疗相比，抑制IL-17A可使血管和心肌功能得到更大的改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f8720336334)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508301, encodeId=19c51508301b1, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Clin Exp Hypertens：阻断IL-12和/或IL-23可改善主动脉血管炎, objectType=article, longId=203361, objectId=d59f203361c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d59f203361c6, replyNumber=0, likeNumber=73, createdTime=2020-11-15, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d59f203361c6, moduleTitle=Clin Exp Hypertens：阻断IL-12和/或IL-23可改善主动脉血管炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d59f203361c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508300, encodeId=fa4b15083008f, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=诺华IL-1β单抗canakinumab治疗新冠COVID-19：未能提高生存率, objectType=article, longId=203185, objectId=8a9e203185f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a9e203185f0, replyNumber=0, likeNumber=73, createdTime=2020-11-11, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a9e203185f0, moduleTitle=诺华IL-1β单抗canakinumab治疗新冠COVID-19：未能提高生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a9e203185f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508299, encodeId=de12150829957, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=诺华的IL-17A单抗Cosentyx在银屑病关节炎III期研究中显著减轻滑膜炎, objectType=article, longId=202989, objectId=b8be20298966, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8be20298966, replyNumber=0, likeNumber=48, createdTime=2020-11-08, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8be20298966, moduleTitle=诺华的IL-17A单抗Cosentyx在银屑病关节炎III期研究中显著减轻滑膜炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8be20298966)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508298, encodeId=36ee150829807, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=头对头3期临床证实：抗IL-17单抗Bimekizumab治疗中度至重度银屑病优于TNF单抗修美乐, objectType=article, longId=202790, objectId=00a7202e904b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00a7202e904b, replyNumber=0, likeNumber=75, createdTime=2020-11-04, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00a7202e904b, moduleTitle=头对头3期临床证实：抗IL-17单抗Bimekizumab治疗中度至重度银屑病优于TNF单抗修美乐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00a7202e904b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508297, encodeId=0b6f150829e57, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=哮喘治疗新突破：IL-15Rα单抗FASENRA让62%的患者摆脱口服糖皮质激素, objectType=article, longId=202761, objectId=152c202e61d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=152c202e61d8, replyNumber=0, likeNumber=75, createdTime=2020-11-03, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=152c202e61d8, moduleTitle=哮喘治疗新突破：IL-15Rα单抗FASENRA让62%的患者摆脱口服糖皮质激素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=152c202e61d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508296, encodeId=d86c15082964c, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作, objectType=article, longId=202084, objectId=58c820208475, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c820208475, replyNumber=0, likeNumber=72, createdTime=2020-10-15, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c820208475, moduleTitle=赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c820208475)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508295, encodeId=dc93150829554, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=J Allergy Clin Immunol：高IL-17型哮喘患者具有银屑病免疫表型, objectType=article, longId=201429, objectId=9c2b20142981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c2b20142981, replyNumber=0, likeNumber=63, createdTime=2020-10-02, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c2b20142981, moduleTitle=J Allergy Clin Immunol：高IL-17型哮喘患者具有银屑病免疫表型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c2b20142981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508294, encodeId=9416150829434, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Acta Neuropathologica: IL-1通过抑制血脑屏障内皮血红素氧合酶-1促进自身免疫性神经炎症, objectType=article, longId=200992, objectId=3f47200992f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f47200992f1, replyNumber=0, likeNumber=0, createdTime=2020-09-22, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f47200992f1, moduleTitle=Acta Neuropathologica: IL-1通过抑制血脑屏障内皮血红素氧合酶-1促进自身免疫性神经炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f47200992f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IL-1

2020-05-29

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

ARD：抑制IL-12/23（优特克单抗）与肿瘤坏死因子在银屑病关节炎中的有效性

2021-11-09

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Lancet Rheumatology: 抑制IL-1和IL-6影响COVID-19患者抗SARS-CoV-2抗体的中和活性

2021-11-03

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

J Invest Dermatol：IL-17A产生细胞在皮肤炎性疾病中的调节

2021-10-28

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

研究进展：细胞因子IL-10生物学和治疗潜力多样性详解

2021-07-04

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Arthritis Res Ther：IL-17抑制剂治疗强直性脊柱炎的疗效和安全性如何？

2021-05-05

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Lancet：IL-17A/F纳米体索洛奇单抗治疗斑块型银屑病II期临床获得成功

2021-04-28

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

BMC Gastroenterology：血浆中IL-17和甲胎蛋白的水平可有效预测肝硬化患者发生肝癌的风险

2021-04-20

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

BMC: 肠粘膜中IL-12表达增加与溃疡性结肠炎的复发有关

2021-03-26

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

ASCO GU 2021: IL-15RαFc超激动剂N-803在对BCG反应的NMIBC膀胱癌原位癌患者中的研究（QUILT 3.032试验）

2021-02-18

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Blood：IL-18介导镰状细胞性心肌病和室性心动过速的发生

2020-12-12

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

恒瑞 IL-17A单抗SHR-1314用于强直性脊柱炎获批临床试验

2020-11-19

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Can J Cardiol：与环孢素或甲氨蝶呤治疗相比，抑制IL-17A可使血管和心肌功能得到更大的改善

2020-11-15

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Clin Exp Hypertens：阻断IL-12和/或IL-23可改善主动脉血管炎

2020-11-15

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

诺华IL-1β单抗canakinumab治疗新冠COVID-19：未能提高生存率

2020-11-11

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

诺华的IL-17A单抗Cosentyx在银屑病关节炎III期研究中显著减轻滑膜炎

2020-11-08

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

头对头3期临床证实：抗IL-17单抗Bimekizumab治疗中度至重度银屑病优于TNF单抗修美乐

2020-11-04

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

哮喘治疗新突破：IL-15Rα单抗FASENRA让62%的患者摆脱口服糖皮质激素

2020-11-03

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作

2020-10-15

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

J Allergy Clin Immunol：高IL-17型哮喘患者具有银屑病免疫表型

2020-10-02

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Acta Neuropathologica: IL-1通过抑制血脑屏障内皮血红素氧合酶-1促进自身免疫性神经炎症

2020-09-22

科室
- - 订阅+
  - 更多科室
工具
服务